Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial-Reference-Cited by-同舟云学术

Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial

Published:2016-06 Issue:6 Volume:195 Page:1825-1829
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kaplan Steven A.¹,Lee Jeannette Y.²,Meehan Alan G.³,Kusek John W.⁴

Affiliation:

1. Department of Urology, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, New York

2. University of Arkansas for Medical Sciences, Little Rock, Arkansas

3. Merck & Co., Inc., Kenilworth, New Jersey

4. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference15 articles.

1. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation;Gur;Expert Opin Drug Saf,2013

2. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia;McConnell;N Engl J Med,2003

3. Food and Drug Administration: HYTRIN—terazosin hydrochloride tablet: Abbott Laboratories, 2009. Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019057s022lbl.pdf. Accessed November 5, 2015.

4. Food and Drug Administration: Highlights of Prescribing Information: Flomax® (tamsulosin hydrochloride) Capsules, 0.4 mg, 2011. Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020579s027lbl.pdf. Accessed November 5, 2015.

5. Food and Drug Administration: Highlights of Prescribing Information: CARDURA® XL (doxazosin mesylate extended release tablets). Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021269s017lbl.pdf. Accessed November 5, 2015.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5-HT6 receptor antagonists. Design, synthesis, and structure–activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines;Bioorganic & Medicinal Chemistry Letters;2023-11

2. Treating LUTS in Men with Benign Prostatic Obstruction: A Review Article;Drugs & Aging;2023-08-09

3. Efficacy and Safety of a Natural Supplement Containing Serenoa Repens, Solanum Lycopersicum, Lycopene, and Bromelain in Reducing Symptoms of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective Cohort Study in 250 Patients;Uro;2023-07-20

4. The Lack of Standardization and Pharmacological Effect Limits the Potential Clinical Usefulness of Phytosterols in Benign Prostatic Hyperplasia;Plants;2023-04-20

5. 5-Ht6 Receptor Antagonists. Design, Synthesis, and Structure-Activity Relationship of Substituted 2-(1-Methyl-4-Piperazinyl)Pyridines;2023